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Background: Visceral leishmaniasis is a disease with great variability regarding the clinical manifestations in humans
and dogs. Chronically infected dogs may develop neurological disorders, however, there are few reports that
characterize the lesions and make clear the pathogenesis of the canine cerebral leishmaniasis. Concomitant with
Leishmania chagasi, dogs may be infected by opportunistic pathogens, such as Toxoplasma gondii and Neospora
caninum, which may contribute to the occurrence of lesions in the central nervous system. Hence, we aimed to
compare the T and B lymphocytes population in the brains of infected dogs with seropositivity to L. chagasi, T.
gondii and N. caninum concurrently (n = 24), seropositivity only to L. chagasi (n = 31), and seropositivity to T. gondii
and N. caninum (n = 16). Uninfected dogs were used as control (n = 10).
Results: Inflammatory lesions, characterised by mononuclear cell accumulation, composed mainly of CD3+ T lymphocytes
predominated in several encephalic regions of the dogs from all the three infected groups, with no difference among
them (P = 0.0004), whereas CD79α+ B lymphocytes were detected in very small intensity and presented no difference
among groups (P = 0.5313). Furthermore, no association among diseases was detected at the serological enquire.
Conclusions: We demonstrate that the peripheral infection by L. chagasi per se can promote the influx of
lymphocytes within the nervous milieu as occurs during Toxoplasma and Neospora infections, and the concomitant
seropositivity against these pathogens does not exacerbate the inflammatory brain lesions. Therefore, these
findings give additional support that the brain should be included in the list of organs affected by visceral
leishmaniasis and that even asymptomatic infected dogs may develop brain lesions.
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LeishmaniasisBackground
Visceral leishmaniasis (VL) is a vector-borne disease caused
by the intracellular protozoan Leishmania chagasi
(Syn = L. infantum) and transmitted by phlebotomine sand
flies. VL is a disease with great variability of clinical mani-
festations, and in dogs it ranges from absence of symptoms
to generalized disorders that may result in the host death,
such as fever, anemia, cachexia, skin lesions, lymphade-* Correspondence: giselem@fmva.unesp.br
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reproduction in any medium, provided the ornopathy, renal alterations and ocular lesions [1-3]. The
clinical manifestations vary according to the host immune
response and to the parasite pathogenicity, which differs
among species [2]. Chronically infected dogs may develop
neurological disorders, however, there are few reports that
characterize the lesions and make clear the pathogenesis of
the canine cerebral leishmaniasis (CCL) [4-7]. Toxoplasmo-
sis is known by causing pulmonary and digestive
disorders, retinal lesions and neuropathies [8-10], and
canine neosporosis is an important cause of neurological
disorders [11,12].ral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Gender and age range of the dogs included in
this study, according to the experimental groups
Group LTN L TN C Total
n % n % n % n % n %
Gender Male 15 62.5 16 51.6 7 43.8 7 70.0 45 55.6
Female 9 37.5 15 48.4 9 56.3 3 30.0 36 44.4
Total 24 100.0 31 100.0 16 100.0 10 100.0 81 100.0
Age
range
0-1 2 8.3 7 22.6 1 6.3 2 20.0 12 14.8
(years) 1-2 3 12.5 9 29.0 4 25.0 2 20.0 18 22.2
2-7 19 79.2 15 48.4 11 68.8 5 50.0 50 61.7
>7 0 0.0 0 0.0 0 0.0 1 10.0 1 1.2
Total 24 100.0 31 100.0 16 100.0 10 100.0 81 100.0
LTN Dogs with seropositivity to visceral leishmaniasis, toxoplasmosis and
neosporosis, L Dogs with seropositivity only to visceral leishmaniasis, TN Dogs
with seropositivity only to toxoplasmosis and/or neosporosis, C Control
healthy dogs.
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due to the parasite ability to modify the host immune
system. During the disease, infected cells from the
mononuclear phagocyte system act as antigen presenting
cells (APCs), stimulating CD4+ T helper (Th) lymphocytes.
Th1 response, mediated by macrophages and pro-
inflammatory cytokines such as TNF-α, IL-2 and IFN-γ is
related to the host ability to control the infection. However,
as an evasion strategy, components of the parasite preferen-
tially activate Th2 lymphocytes and when the Th2 response
predominates, the production of anti-inflammatory cyto-
kines such as IL-4, IL-10 and TGF-β occurs, resulting in B
lymphocytes proliferation and subsequent production of
antibodies, mainly IgG, which are not effective against the
parasite [2,13-15].
The involvement of the host immune system due to
the Leishmania infection [16] may be related to the
infection by other pathogens. In humans, the association
between VL and AIDS is becoming common in VL
endemic areas and HIV/Leishmania co-infection is
considered an emerging disease [17,18]. Concomitant
incidence of VL, neosporosis and toxoplasmosis in dogs
have already been described in the region of the municipal-
ity of Araçatuba, São Paulo State, Brazil, an endemic area
for VL [19]. Toxoplasmosis is an opportunistic disease
related to immunosuppressive status [9,10,19,20] and
association between canine VL and neosporosis has
also been detected [19,21,22]. Recently, Lindsay et al.
[23] confirmed the role of dogs as the definitive host of
N. caninum, and even if dogs are not the definitive host
of T. gondii, they may collaborate with mechanical dis-
semination of toxoplasmosis [9].
VL may be associated to an immunosuppressive state
[13,14] and the contact between the host with the oppor-
tunist pathogens Toxoplasma gondii and Neospora caninum
possibly will contribute to the occurrence of lesions in the
central nervous system (CNS). Recently, we demonstrated
that dogs with VL presented encephalic lesions compatible
with encephalitis or at least, that the nervous milieu
presented a pro-inflammatory status [5,24,25]. Hence,
the aim of this study was to compare the lymphocytes
population (T and B cells) in the brains of seropositive
dogs to L. chagasi with those observed in dogs with
seropositivity to T. gondii and N. caninum.
Methods
Animals
Eighty-one mixed-breed, male and female, adult dogs,
which were referred to the Veterinary Teaching Hospital at
UNESP - São Paulo State University, and to the local
Zoonosis Control Center, between August/2006 and
June/2009, were used in this study. The municipality of
Araçatuba is an endemic area for VL with a seroprevalence
of canine VL of 12% [26]. Blood samples were collectedbefore the dogs were euthanized, in compliance with the
State law, with an overdose of pentobarbital and potassium
chloride. Necropsies were performed immediately after
euthanasia, and gross lesions were recorded. None of the
animals presented history of neurological symptoms.
Parasitological and serological analysis
The diagnosis of VL was achieved by serological and
parasitological examinations. Serological diagnosis was
done using ELISA tests as described by Lima et al. [27]
with the lower limit of positivity (cut-off ) considered as
0.270 (optical density). Parasitological diagnosis of VL
was achieved by finding typical amastigotes forms of
Leishmania in cytological examinations of tissue smears
from the popliteal lymph node.
The serological diagnosis of toxoplasmosis and
neosporosis was performed using indirect immunofluores-
cence assays as described by Varandas et al. [28], being
considered seropositives those dogs presenting antibody
titer equal to or greater than 1:16 and 1:50, respectively.
Experimental design
The dogs were divided into four experimental groups:
(1) the LTN group was composed of 24 dogs with
concurrent seropositivity to VL, toxoplasmosis and/or
to neosporosis; (2) the L group was constituted by 31
dogs with seropositivity only to VL; (3) the TN group
was composed of 16 dogs with negative diagnosis to
VL and with seropositivity to toxoplasmosis and/or to
neosporosis; and (4) the C group, constituted by 10
control healthy dogs with negative diagnosis for VL,
toxoplasmosis and neosporosis, which death have not
been related to CNS injury and which were referred by the
owners to the Animal Pathology Service of UNESP - São
Paulo State University in Araçatuba (Table 1). Age and
gender were not taken into account in the analyses, since
Table 2 Occurrence of antibodies anti-Toxoplasma gondii
and anti-Neospora caninum in dogs according to the
positive or negative serology to visceral leishmaniasis
Group Condition Dogs
n %
LTN L. chagasi positive, T. gondii positive
and N. caninum positive
12 14.8
LTN L. chagasi positive, T. gondii positive
and N. caninum negative
4 4.9
LTN L. chagasi positive, T. gondii negative
and N. caninum positive
8 9.9
L L. chagasi positive, T. gondii negative
and N. caninum negative
31 38.3
Subtotal 55 67.9
TN L. chagasi negative, T. gondii positive
and N. caninum positive
4 4.9
TN L. chagasi negative, T. gondii positive
and N. caninum negative
8 9.9
TN L. chagasi negative, T. gondii negative
and N. caninum positive
4 4.9
C L. chagasi negative, T. gondii negative
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or age and the prevalence of toxoplasmosis, neosporosis or
visceral leishmaniasis.
Histopathology and immunohistochemistry (IHC)
The brain was sagitally sliced after removal and fixed in
10% neutral buffered formalin. Tissue samples were
paraffin-embedded, sectioned (4 μm) and stained with
haematoxylin & eosin (HE) using routine protocols. The
following areas were evaluated for lesions: ventricular
choroid plexi, ependyma and sub-ependymal area, lepto-
meninges in the temporal and piriform cortex and in the
thalamus. The histopathological examination was done to
verify the presence of inflammatory cells particularly in
the perivascular, ventricular and sub-meningeal spaces.
IHC stains were performed using standard streptavidin-
biotin peroxidase (HRP) immunostaining with polyclonal
rabbit anti-human CD3 antibody (Dako A0452, Carpinteria,
CA, USA) to detect CD3+ T lymphocytes, and the
monoclonal mouse anti-human CD79αcy antibody
(Dako M7051, Carpinteria, CA, USA) to identify CD79α+ B
lymphocytes. Slides were deparaffinised in xylene and
hydrated through graded alcohols. Antigen retrieval
was achieved by steam heating in Tris-EDTA buffer
plus 0.05% (v/v) Tween-20, pH 9.0, for 30 minutes. To
inhibit endogenous peroxidase, slides were incubated
with 2% (v/v) hydrogen peroxide 30 vol. diluted in 50%
(v/v) methanol and deionized water for 30 minutes,
and nonspecific binding was blocked with 3% (w/v)
non-fat dry milk in phosphate-buffered saline (PBS)
pH 7.2 for 30 minutes. Primary antibodies against CD3
(1:100), and CD79α (1:50) were applied for 18–22 hours
at 4°C in a humidified chamber. Slides were washed in
PBS, incubated with a biotinylated secondary antibody
and streptavidin-HRP complex (Dako K0690 LSAB+ Kit,
Carpinteria, CA, USA), then the reaction was developed
with 3,3′-diaminobenzidine (Dako K3468, Carpinteria,
CA, USA) and counterstained with Harris’s haematoxylin,
dehydrated, cleared with xylene, and mounted with cover
slips. For internal IHC control, sections of canine lymph
node were used as positive control, and for negative con-
trol the primary antibody incubation was skipped in some
slides. Tissue sections were examined by light microscopy.
The presence of immunostained cells was analysed colori-
metrically, quantifying the percentage of the immuno-
stained area in relation to the total area, using the software
Image-Pro Plus 6.1 (Media Cybernetics, Bethesda, MA,
USA) according to the guidelines described by Melo and
Machado [24]. Twenty images representative of twenty
microscopic fields (90,506.04 μm2 per field, at the magnifi-
cation of 40×) were obtained in four pre-defined encephalic
areas: (1) leptomeninges in the temporal and piriform
cortex; (2) ependyma and sub-ependymal area in the
hippocampus; (3) leptomeninges in the thalamus; and(4) choroid plexus in the lateral ventricle, in a total area of
1,810,120.7 μm2. Examinations were done “blindly”, with-
out knowledge of the experimental groups.
Statistical analysis
The differences between groups were determined by
the Kruskal-Wallis test followed by Dunn’s multiple
comparison test. Association between the diseases was
analysed using the Fisher’s exact test, and data were
submitted to Spearman correlation test. A value of P < 0.05
was considered statistically significant. Data are expressed
as the median (minimum - maximum), and all statis-
tical analyses were performed using Prism 5 software
(GraphPad, La Jolla, CA, USA).
Ethics
This study was approved by the Institutional Ethics and
Animal Welfare Committee (CEEA – Comissão de Ética
e Experimentação Animal, UNESP – São Paulo State
University, process number 05/06).
Results
Serological evaluation
No association between VL and the presence of anti-N.
caninum antibodies (Fisher’s exact test: P = 0.8029) was
detected, as well as between VL and the presence of
anti-T. gondii antibodies (Fisher’s exact test: P = 0.1431).
Table 2 illustrates the results of the serological enquire
of the dogs according to the four experimental groups.
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Additional file 1: Table S1.
Necroscopic examination
The gross lesions found in the necroscopic examination
are listed in Table 3. The main alteration observed in the
dogs from the L group consisted by lymphadenopathy,
skin lesions (ulcerations, alopecia, hyperpigmentation,
seborrhoea, ear pinna ulcer), splenomegaly and weight
loss/cachexia. Animals from TN group presented with
skin lesions (alopecia, seborrhoea) as the major alteration,
and few dogs showed lymphadenopathy, weight loss and
splenomegaly, as well as other lesions, such as oral ulcer-
ation, hepatic lesions and hepatomegaly. In the dogs from
the LTN group, it was observed the same alterations
found in L and TN group, and further findings, such as
eye lesions (blepharitis, purulent keratoconjunctivitis) and
evident splenic white pulp. In all experimental groups, a
high amount of dogs presented no macroscopic alterations
and consequently they were considered asymptomatic. All
alterations observed in the dogs were consistent with VL
lesions and no other characteristic alteration of toxoplas-
mosis or neosporosis were detected.
Histopathological findings
Remarkable inflammatory lesions were found in the
nervous tissue of the dogs from all the infected groups.
Inflammatory lesions, characterised by mononuclear
cells, focal or coalescent multifocal accumulation, ranged in
intensity from mild to severe. The lesions were composed
mainly by lymphocytic cells, and they were evidenced in
several encephalic regions, principally at the choroid plexus,
ependyma and sub-ependymal area, leptomeninges and
sub-meningeal areas, as well as in the perivascular spaces inTable 3 Gross lesions found in the necroscopic examination
of the dogs, according to the experimental groups
Alteration 1 LTN group L group TN group C group
(n = 24) (n = 31) (n = 16) (n = 10)
n % n % n % n %
Evident splenic white pulp 2 8.3 1 3.2 - - - -
Eye lesion 3 12.5 - - - - - -
Lymphadenopathy 10 41.7 13 41.9 2 12.5 - -
Onycogryphosis 1 4.2 1 3.2 - - - -
Skin lesion 11 45.8 8 25.8 6 37.5 - -
Splenomegaly 2 8.3 3 9.7 2 12.5 - -
Weight loss 2 8.3 3 9.7 2 12.5 - -
Other - - - - 3 18.8 - -
No alteration 5 20.8 13 41.9 9 56.3 10 100.0
1One animal could have presented more than one alteration (n = 81).
LTN Dogs with seropositivity to visceral leishmaniasis, toxoplasmosis and
neosporosis, L Dogs with seropositivity only to visceral leishmaniasis, TN Dogs
with seropositivity only to toxoplasmosis and/or neosporosis, C Control
healthy dogs.the brain parenchyma (Table 4). Minimal or no alterations
were found in the dogs from the C group, and when some
alteration was identified, it was constituted by blood vessel
walls hyalinization. None of the dogs presented typical
amastigotes forms of Leishmania and either characteristic
cysts of Toxoplasma or Neospora in the nervous tissue.
Lymphocytes in the nervous tissue
CD3+ T lymphocytes predominated in the infected
groups, when compared to control group (Kruskal-
Wallis test: P = 0.0004). The LTN group presented, as the
median value, 1.02% (0.13 - 13.96) of CD3 immunostained
area, 1.66% (0.00 - 14.46) in the L group, and 2.42%
(1.02 - 7.26) in the TN group, with no difference among
them. The C group presented only 0.19% (0.01 - 0.47) of
CD3 immunostained area (Figure 1a). Regarding CD79α+
B lymphocytes (Figure 1b), the LTN group presented 0.01%
(0.00 - 0.44) of CD79α immunostained area, the L group
0.00% (0.00 - 2.83), the TN group 0.00% (0.00 - 2.66),
and the C group 0.00% (0.00 - 0.02), with no significative
difference among them (Kruskal-Wallis test: P = 0.5313).
CD3+ T lymphocytes were primarily distinguished as
the major component of the inflammatory infiltrate
around parenchymal blood vessels, in the ependymal
zone, in the leptomeninges, as well as in the choroid
plexus (Figure 2a-d). CD79α+ B lymphocytes, even if in
small number, were detected basically in the leptomenin-
ges and in the choroid plexus (Figure 2e-f ). Evaluation
of inflammatory cells presence according specific areas
of the nervous tissue (choroid plexus, ependyma and
leptomeninges) did not result in statistical relevance for
CD3+ T lymphocytes (Kruskal-Wallis test: P = 0.8043)
and neither for CD79α+ B lymphocytes (Kruskal-Wallis
test: P = 0.0714). The correlation between antibody titers
and cellularity was also tested. Correlation between T.
gondii-antibody titers and CD3+ T lymphocytes was notTable 4 Histopathological alterations observed in the
brains of the dogs, according to the experimental groups
Alteration 1 LTN group L group TN group C group
(n = 24) (n = 31) (n = 16) (n = 10)
n % n % n % n %
Blood vessel walls
hyalinization (choroid plexus)
3 12.5 9 29.0 1 6.3 3 30.0
Blood vessel walls
hyalinization (leptomeninges)
4 16.7 4 12.9 1 6.3 1 10.0
Ependymal rosettes 2 8.3 2 6.5 - - - -
Inflammatory lesions 2 18 75.0 17 54.8 10 62.5 - -
Microhemorrhages 3 12.5 - - 1 6.3 - -
No alteration 6 25.0 7 22.6 5 31.3 6 60.0
1One animal could have presented more than one alteration (n = 81).
2Inflammatory lesions, predominantly mononuclear cell infiltrates, at the
choroid plexus, ependyma, leptomeninges and around parenchymal blood
vessels (perivascular cuffs).
Figure 1 Scatter plots showing the presence of T and B
lymphocytes in the nervous tissue of the dogs. a: CD3+ T
lymphocytes. b: CD79α + B lymphocytes. Data are expressed as the
percentage of immunostained area in relation to the total area,
analysed colorimetrically by the software Image Pro-Plus 6.1. Horizontal
lines indicate median (estimator of position measure) and the
interquartile range (estimator of dispersion measure). LTN: dogs with
seropositivity to visceral leishmaniasis, toxoplasmosis and neosporosis.
L: dogs with seropositivity only for visceral leishmaniasis. TN: dogs with
seropositive diagnosis only for toxoplasmosis and/or neosporosis. C:
control healthy dogs. (* indicates P < 0.05).
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N. caninum-antibody titers and CD3+ T lymphocytes
(Spearman test: P = 0.5857).
Discussion
The data presented herein provide a picture of the
lymphocyte population within the brain of dogs with
seropositivity to visceral leishmaniasis, toxoplasmosis and
neosporosis. Although L. chagasi,T. gondii and N. caninum
are important pathogens, a high amount of the dogs
presented no alterations at the necroscopic examination
and consequently they were considered asymptomatic.
An important epidemiological characteristic of VL is
that infected dogs may remain asymptomatic for a long
period and may never develop the clinical disease [2,14].However, the presence or absence of clinical symptoms
did not influence the histopathological lesions in the
nervous tissue of naturally infected dogs [25]. None of the
dogs presented signs of neurological disorder and no
characteristic alterations of toxoplasmosis or neosporosis
was observed, except for lymphadenopathy, which was the
only symptom observed in the dogs that have been experi-
mentally infected by different strains of. T. gondii [8].
Clinical neosporosis in adult dogs is generally related
to the reactivation of a previous infection due to an
immunosuppressive status [29], and the occurrence of
clinical signs is associated with antibody titer greater
than 1:800, while antibody titers equal to or greater than
1:50 only indicate exposure to the parasite [28]. Regarding
toxoplasmosis, during experimental infection, some dogs
keep asymptomatic, few dogs develop clinical signs and
deaths are rarely seen [8].
Even if association among these diseases were not
detected, 43.6% (24/55) of the dogs with VL presented
antibody titers for T. gondii and/or N. caninum, and on
the other hand, 61.5% (16/26) of the dogs diagnosed
without VL presented antibody titers for T. gondii and/
or N. caninum. The presence of positive antibody titer
for toxoplasmosis and/or neosporosis in animals with
VL did not influence the amount of CD3+ cells within
the brain, as occurred in the dogs infected only by L.
chagasi or in seropositive dogs only for T. gondii and/or
N. caninum. All of these three conditions rendered
favourable the accumulation of CD3+ T lymphocytes in
the nervous milieu, since there was evident difference
when compared to control group. Further, the great
variability observed among the number of CD3+ T lym-
phocytes detected in the dogs within the same group is
likely to be due to the natural character of the infection.
Regarding the CD79α+ B lymphocytes, the presence of
these cells was not significant in none of the above
mentioned conditions, as the CD79α immunostaining was
minimal and rather equivalent among groups. Although
these cells play a role in the peripheral immune response
against VL, they seem not to take part in the response
within the brain.
The concomitance of VL, toxoplasmosis and neosporosis
might be a propitious condition to the occurrence of neuro-
logical disorders. Alone, VL may promote an influx of a
high amount of T lymphocytes, few phagocytic and B cells
in the nervous tissue, primarily in the choroid plexus and
leptomeninges, as well as high index of astroglial and
microglial activation [24,25]. Further, the severity of the
histopathological lesions and the presence of clinical
neurological manifestation in dogs with VL seem not to be
correlated [4]. Moreover, toxoplasmosis might promotes
mononuclear meningitis as well as mononuclear perivas-
cular cuffs [8] and in mice experimentally infected by N.
caninum, the main encephalic alteration was encephalitis,
Figure 2 Representative photomicrographies of immunohistochemical detection of CD3+ and CD79α+ lymphocytes within the nervous
tissue of dogs (LTN group). a: CD3+ T lymphocytes in the leptomeninges (arrow) from the temporal cortex as the major component of the
inflammatory infiltrate. b: Disperse CD3+ T lymphocytes in the choroid plexus (arrowhead) and in the sub-ependymal area (arrow). c: Inflammatory
infiltrate composed of CD3+ T lymphocytes (arrow) in the lateral ventricular ependyma. Note that the immunostained cells are just under the
ciliated cells monolayer (arrowhead) that forms the ependyma. d: Perivascular cuff constituted mainly by CD3+ T lymphocytes (arrow) in the
thalamus. e: Presence of two CD79α+ B cells (arrow) in the subependymal area. f: Few CD79α+ B cells (arrow) in the same perivascular cuff in the
thalamus shown in d. Streptavidin–biotin peroxidase complex method. Scale bar = 50 μm.
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of these histopathological alterations were detected in the
brains of dogs included in this study, with inflammatory
infiltrates being the most prevalent.
The activation of a systemic immune response promotes
the peripheral activation of lymphocytes and their
migration across the blood–brain-barrier (BBB) into
the nervous environment and brain parenchyma, as
previously described by some researchers [30-35]. BBB is
extremely susceptible to the action of cytokines, which
might activate the endothelial cells and increase the
permeability of the barrier [36].The anti-Leishmania immune response also includes
the production of several cytokines [2,37], which might
modulate the BBB selective filtration and allow the passage
of inflammatory mediators and immunoglobulins [38].
Receptors for the Fc portion of the immunoglobulins
are present in immune cells (mast cells, lymphocytes,
macrophages) and also in neurons and glial cells. The
activation of these receptors starts a succession of bio-
logical processes including phagocytosis, degranulation
and cytokine genes activation [39,40]. High titers of
anti-Leishmania antibodies in the CSF have already
been described in dogs with natural VL [4,25,41,42],
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within the CNS may contribute to the beginning of the
inflammatory process, as previously described in immune-
mediated and degenerative diseases of CNS [43,44].
Conclusion
In dogs, VL can be associated with an influx of CD3+ T
lymphocytes in the brain similarly as occurs during toxo-
plasmosis and neosporosis, and the concomitant presence
of serum antibodies against Leishmania, Toxoplasma
and Neospora does not exacerbate the inflammatory
brain lesions. In animals presenting with neurological
signs, the use of serological tests is an important tool
to diagnose toxoplasmosis or neosporosis, and the en-
cephalitis caused by these agents presents a well described
pattern [8,9,11,12,28]. Nevertheless, this and other studies
[4,24,25,42,45] demonstrated that the peripheral infection
by L. chagasi per se can promote the influx of lymphocytes
and other inflammatory changes within the nervous
milieu. Therefore, these findings give additional support
that the brain should be included in the list of organs af-
fected by visceral leishmaniasis and that even asymptomatic
infected dogs may develop brain lesions. Finally, VL has
to be considered as differential diagnosis for inflammatory
lesions in the brain.
Additional file
Additional file 1: Table S1. Individual data from each dog included in
the experimental groups.
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